ISRCTN16732324
Completed
未知
Optimised inhalers to reduce chronic obstructive pulmonary disease exacerbation re-admissions and mortality: a feasibility study
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Exacerbations of chronic obstructive pulmonary disease (COPD)
- Sponsor
- Royal Free London NHS Foundation Trust
- Enrollment
- 300
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38444664/ (added 19/07/2024)
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. In hospital with an exacerbation of COPD
- •2\. Age 18 years or over
- •3\. Able to provide informed consent
Exclusion Criteria
- •Discharge home with palliative care
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)CHRONIC OBSTRUCTIVE PULMONARY DISEASEASTHMAHEALTHY SUBJECTSNCT01721291Imperial College London65
Recruiting
Not Applicable
Assessing Optimal Inhaler Strategies During Acute Exacerbations of COPD (AECOPDs) Using OscillometryCOPDCOPD Exacerbation AcuteNCT06495047McGill University Health Centre/Research Institute of the McGill University Health Centre43
Completed
Not Applicable
Improving completion of pulmonary rehabilitation with PR-buddies (IMPROVE)Chronic obstructive pulmonary diseaseRespiratoryISRCTN12658458King's College London1,577
Completed
Phase 2
Safety and Tolerability of QVA149 (Indacaterol/Glycopyrrolate) Compared to Placebo and to Indacaterol in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary Disease (COPD)NCT00558285Novartis257
Completed
Not Applicable
Intervention to Reduce Misused Inhaler and Insufficient Peak Inspiratory Flow in Hospitalized COPD PatientsCOPDNCT05207631Hôpital Fribourgeois101